| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |